Treatment of mild obstructive sleep apnea syndrome (OSAS) with excessive daytime sleepiness: a randomised controlled single blind trial of CPAP versus nasal strips

J. Verbraecken, S. Valgaeren, C. Decooman, O. Van Reeth, A. Boudewyns, F. Baharloo, G. Liistro, D. Rodenstein (Antwerp (Edegem), Brussels, Liège, Belgium)

Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Session: Treatment options in obstructive sleep apnoea
Session type: Electronic Poster Discussion
Number: 2775
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Verbraecken, S. Valgaeren, C. Decooman, O. Van Reeth, A. Boudewyns, F. Baharloo, G. Liistro, D. Rodenstein (Antwerp (Edegem), Brussels, Liège, Belgium). Treatment of mild obstructive sleep apnea syndrome (OSAS) with excessive daytime sleepiness: a randomised controlled single blind trial of CPAP versus nasal strips. Eur Respir J 2007; 30: Suppl. 51, 2775

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A randomized controlled trial of auto-titrating continuous positive airway pressure treatment for obstructive sleep apnoea after acute quadriplegia (COSAQ)
Source: International Congress 2016 – Epidemiological aspects of obstructive sleep apnoea
Year: 2016

Impaired control of gait in severe obstructive sleep apnea and continuous positive airway pressure treatment: a randomized controlled trial
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019


Randomized trial of oropharyngeal exercises plus incentive spirometry on patients with mild to moderate obstructive sleep apnea syndrome
Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options
Year: 2018



The 5-min pupillary alertness test is sensitive to modafinil: a placebo controlled study in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007


Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial
Source: Eur Respir J, 51 (5) 1800032; 10.1183/13993003.00032-2018
Year: 2018



Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study
Source: Eur Respir J 2009; 33: 1062-1067
Year: 2009



Impact of continuous positive airway pressure (CPAP) on chronic cough in obstructive sleep apnoea (OSA) – A randomized controlled trial
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Residual sleepiness in obstructive sleep apnea (OSA) patients on CPAP: Not only a symptom but rather a true syndrome?
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Acetazolamide reduces blood pressure and sleep disordered breathing in hypertensive obstructive sleep apnoea patients – a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017

Impact on objective cough severity by continuous positive airway pressure (CPAP) in subjects with chronic cough and obstructive sleep apnoea – A randomized controlled trial
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011


A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea
Source: Eur Respir J 2010; 35: 138-145
Year: 2010



Effect of 1 month of zopiclone on obstructive sleep apnoea severity and symptoms: a randomised controlled trial
Source: Eur Respir J, 52 (1) 1800149; 10.1183/13993003.00149-2018
Year: 2018



Effect of multiple-dose treatment with daridorexant on nighttime respiratory function in patients with mild and moderate obstructive sleep apnea (OSA)
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020


Morphine alters respiratory control but not other key obstructive sleep apnoea phenotypes: a randomised trial
Source: Eur Respir J, 55 (6) 1901344; 10.1183/13993003.01344-2019
Year: 2020



Obstructive sleep apnea (OSA) in elderly patients. Role of continuos positive airway pressure (CPAP) treatment. A multicenter randomized controlled clinical trial
Source: International Congress 2014 – Three ages of man: OSA in children, adults and the elderly
Year: 2014



CPAP trial in patients with significant sleep apnoea but few symptoms or mild sleep apnoea with marked symptoms – a retrospective audit
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007


Treatment of obstructive sleep apnea during decompensations of heart hailure a randomized controlled trial
Source: International Congress 2017 – CPAP therapy
Year: 2017

Effects of suboptimal adherence of CPAP therapy on symptoms of obstructive sleep apnoea: a randomised, double-blind, controlled trial
Source: Eur Respir J, 55 (3) 1901526; 10.1183/13993003.01526-2019
Year: 2020



The need of higher CPAP pressure in a population with obstructive sleep apnea (OSA) and refractory hypertension (RHT) versus controlled hypertension-a retrospective study
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012

Impact of a short rehabilitation program on fat visceral and blood pressure on patients with obstructive sleep apnea syndrome (OSAS). A randomized controlled study
Source: Annual Congress 2007 - Pulmonary rehabilitation beyond training
Year: 2007